← Back to Search

Treatment Group for Epilepsy (HOBSCOTCH Trial)

N/A
Waitlist Available
Research Sponsored by Kessler Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights

HOBSCOTCH Trial Summary

This trial will test whether a phone intervention called HOBSCOTCH can improve health and quality of life for people with refractory epilepsy.

Eligible Conditions
  • Epilepsy

HOBSCOTCH Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline & 8-10 weeks after baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline & 8-10 weeks after baseline for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in Quality of Life in Epilepsy - 31 score
Secondary outcome measures
Feasibility of HOBSCOTCH in the clinical setting

HOBSCOTCH Trial Design

1Treatment groups
Experimental Treatment
Group I: Treatment GroupExperimental Treatment1 Intervention

Find a Location

Who is running the clinical trial?

Kessler FoundationLead Sponsor
173 Previous Clinical Trials
10,678 Total Patients Enrolled
NYU Langone HealthOTHER
1,367 Previous Clinical Trials
839,691 Total Patients Enrolled
25 Trials studying Epilepsy
3,013 Patients Enrolled for Epilepsy

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~5 spots leftby Apr 2025